Autor: "Carson PE" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
Autorzy:: Shen L; Department of Cardiology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Rørth R; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Cosmi D; Department of Cardiology, Hospital of Gubbio, Gubbio, Italy.
Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Cosmi F; Department of Cardiology, Hospital of Cortona, Cortona, Italy.
Latini R; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark.
Anand IS; Department of Medicine, University of Minnesota Medical School and VA Medical Center, Minneapolis, MN, USA.
Carson PE; Department of Cardiology, Washington VA Medical Center, Washington, DC, USA.
Granger CB; Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Komajda M; Department of Cardiology, Hospital Saint Joseph, Paris, France.
McKelvie RS; Western University, London, Ontario, Canada.
Solomon SD; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Staszewsky L; Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, UK.
Huynh T; McGill Health University Center, Division of Cardiology, Montreal, Quebec, Canada.
Zile MR; Medical University of South Carolina and Ralph H. Johnston Veterans Administration Medical Center, Charleston, SC, USA.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2019 Aug; Vol. 21 (8), pp. 974-984. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus, Type 2/*drug therapy
Heart Failure/*physiopathology
Insulin/*therapeutic use
Stroke Volume/*physiology
Ventricular Function, Left/*physiology
Aged ; Cause of Death/trends ; Diabetes Mellitus, Type 2/complications ; Female ; Global Health ; Heart Failure/diagnosis ; Heart Failure/mortality ; Hospitalization/trends ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Survival Rate/trends

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
Autorzy:: Kao DP; University of Colorado School of Medicine, Aurora, CO, USA.
Lewsey JD; University of Glasgow, Glasgow, UK.
Anand IS; Veterans Affairs Medical Center and University of Minnesota, Minneapolis, MN, USA.
Massie BM; University of California San Francisco, San Francisco, CA, USA.
Zile MR; Medical University of South Carolina and the RHF Department of Veterans Affairs Medical Center, Charleston, SC, USA.
Carson PE; Washington Veterans Affairs Medical Center and Georgetown University, Washington, DC, USA.
McKelvie RS; Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.
Komajda M; University Pierre et Marie Curie Paris VI, La Pitié-Salpétrière Hospital Paris, France.
McMurray JJ; University of Glasgow, Glasgow, UK.
Lindenfeld J; University of Colorado School of Medicine, Aurora, CO, USA.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Sep; Vol. 17 (9), pp. 925-35. Date of Electronic Publication: 2015 Aug 06.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Biphenyl Compounds/*administration & dosage
Heart Failure/*physiopathology
Stroke Volume/*physiology
Tetrazoles/*administration & dosage
Aged ; Aged, 80 and over ; Angiotensin II ; Angiotensin II Type 1 Receptor Blockers/administration & dosage ; Cause of Death/trends ; Dose-Response Relationship, Drug ; Female ; Follow-Up Studies ; Heart Failure/drug therapy ; Heart Failure/mortality ; Humans ; Irbesartan ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Survival Rate/trends ; United Kingdom/epidemiology ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
Autorzy:: Kristensen SL; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK; Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark.
Jhund PS
Køber L
Preiss D
Kjekshus J
McKelvie RS
Zile MR
Anand IS
Wikstrand J
Wedel H
Komajda M
Carson PE
Cleland JG
McMurray JJ; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Feb; Vol. 17 (2), pp. 169-76. Date of Electronic Publication: 2014 Dec 30.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Patient Outcome Assessment*
Heart Failure/*diagnosis
Hospitalization/*statistics & numerical data
Myocardial Infarction/*diagnosis
Stroke/*diagnosis
Stroke Volume/*physiology
Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: A prediction model for sudden cardiac death in patients with heart failure and preserved ejection fraction.
Autorzy:: Adabag S; Veterans Affairs Health Care System, Minnesota, MN, USA; University of Minnesota, Minnesota, MN, USA.
Rector TS
Anand IS
McMurray JJ
Zile M
Komajda M
McKelvie RS
Massie B
Carson PE; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2014 Nov; Vol. 16 (11), pp. 1175-82. Date of Electronic Publication: 2014 Oct 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Death, Sudden, Cardiac/*etiology
Heart Failure/*complications
Heart Failure/*physiopathology
Stroke Volume/*physiology
Aged ; Female ; Humans ; Incidence ; Male ; Multicenter Studies as Topic ; Predictive Value of Tests ; Randomized Controlled Trials as Topic ; Risk Factors ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
Autorzy:: McMurray JJ; Department of Cardiology, Western Infirmary, Glasgow, and Faculty of Medicine, University of Glasgow, Scotland, UK. />Carson PE
Komajda M
McKelvie R
Zile MR
Ptaszynska A
Staiger C
Donovan JM
Massie BM; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2008 Feb; Vol. 10 (2), pp. 149-56.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Stroke Volume*
Heart Failure/*physiopathology
Aged ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Atrial Fibrillation/epidemiology ; Biphenyl Compounds/therapeutic use ; Body Mass Index ; Diabetic Angiopathies/epidemiology ; Female ; Heart Failure/drug therapy ; Humans ; Irbesartan ; Male ; Tetrazoles/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium.
Autorzy:: Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, USA.
Psotka MA; Inova Heart and Vascular Institute, Falls Church, VA, USA.
Fiuzat M; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Filippatos G; University of Cyprus Medical School, Shakolas Educational Center for Clinical Medicine, Nicosia, Cyprus.
Lindenfeld J; Heart Failure and Transplantation Section, Vanderbilt Heart and Vascular Institute, Nashville, TN, USA.
Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Ambardekar AV; Division of Cardiology, University of Colorado, Aurora, CO, USA.
Carson PE; Department of Cardiology, Washington Veterans Affairs Medical Center, Washington, DC, USA.
Jacob R; Patient Representative, Dublin, OH, USA.
Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital, Cardiometabolic Trials, Baim Institute for Clinical Research, Boston, MA, USA.
Konstam MA; The CardioVascular Center of Tufts Medical Center, Boston, MA, USA.
Krucoff MW; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Lewis EF; Division of Cardiovascular Medicine, Stanford University, Palo Alto, CA, USA.
Piccini JP; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.
Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Stockbridge N; United States Food and Drug Administration, Silver Spring, MD, USA.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
Unger EF; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Zeitler EP; Dartmouth-Hitchcock Medical Center and The Dartmouth Institute, Lebanon, NH, USA.
Anker SD; Division of Cardiology and Metabolism, Department of Cardiology, Berlin-Brandenburg Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
O'Connor CM; Inova Heart and Vascular Institute, Falls Church, VA, USA.; Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2020 Dec; Vol. 22 (12), pp. 2175-2186. Date of Electronic Publication: 2020 Nov 13.
Typ publikacji:: Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Heart Failure*/diagnosis
Heart Failure*/epidemiology
Heart Failure*/etiology
Heart Failure*/therapy
Terminology as Topic*
Clinical Trials as Topic/*standards
Cardiac Resynchronization Therapy ; Cardiovascular Agents/therapeutic use ; Comorbidity ; Consensus ; Defibrillators, Implantable ; Diagnostic Techniques, Cardiovascular/standards ; Electric Countershock/instrumentation ; Endpoint Determination/standards ; Europe ; Hospitalization ; Humans ; Patient Reported Outcome Measures ; Quality of Life ; Treatment Outcome ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial.
Autorzy:: Cannon JA; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Shen L; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Jhund PS; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.
Anand IS; Division of Cardiology, University of Minnesota, Minneapolis, MN, USA.
Komajda M; Université Paris 6 and Hospital Pitié-Salpétrière, Paris, France.
McKelvie RS; Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
Zile MR; Ralph H. Johnsons Veterans Affairs Medical Center and, Medical University of South Carolina, Charleston, SC, USA.
Carson PE; Georgetown University and Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
McMurray JJ; Institute of Cardiovascular and Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, Scotland, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2016 Aug; Vol. 18 (8), pp. 1021-31. Date of Electronic Publication: 2016 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Angiotensin II Type 1 Receptor Blockers/*therapeutic use
Biphenyl Compounds/*therapeutic use
Bundle-Branch Block/*physiopathology
Heart Failure/*drug therapy
Tetrazoles/*therapeutic use
Aged ; Bundle-Branch Block/complications ; Cause of Death ; Female ; Heart Failure/blood ; Heart Failure/complications ; Heart Failure/physiopathology ; Hospitalization/statistics & numerical data ; Humans ; Irbesartan ; Male ; Middle Aged ; Mortality ; Natriuretic Peptide, Brain/blood ; Peptide Fragments/blood ; Prognosis ; Proportional Hazards Models ; Severity of Illness Index ; Stroke Volume ; Systole

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Autorzy:: Jhund PS; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Anand IS; Veterans Affairs Medical Center and University of Minnesota, Minneapolis, MN, USA.
Komajda M; Université Paris 6 and Hospital Pitié-Salpêtrière, Paris, France.
Claggett BL; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
McKelvie RS; Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada.
Zile MR; Ralph H. Johnson Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, SC, USA.
Carson PE; Georgetown University and Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
McMurray JJ; BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Aug; Vol. 17 (8), pp. 809-17. Date of Electronic Publication: 2015 Apr 29.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers/*blood
Heart Failure/*physiopathology
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Aged ; Female ; Heart Failure/blood ; Heart Failure/mortality ; Hospitalization ; Humans ; Male ; Prognosis ; Stroke Volume ; Treatment Outcome